Buprenorphine Opioid Treatment During the COVID-19 Pandemic.

Luigi, Mimosa; Luo, Michael; Maes, Etienne J P

Luigi, Mimosa; Luo, Michael; Maes, Etienne J P.

Luigi M; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
Luo M; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
Maes EJP; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

JAMA Intern Med ; 181(8): 1135, 2021 08 01.

Article in English | MEDLINE | ID: covidwho-1176225

Subject(s)

Buprenorphine; COVID-19; Opioid-Related Disorders; Analgesics, Opioid/therapeutic use; Buprenorphine/therapeutic use; Humans; Opiate Substitution Treatment; Opioid-Related Disorders/drug therapy; Opioid-Related Disorders/epidemiology; Opioid-Related Disorders/prevention & control; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Observational study Limits: Humans Language: English Journal: JAMA Intern Med Year: 2021 Document Type: Article Affiliation country: Jamainternmed.2021.0777

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google